Assignee
TARGACEPT INC
US62 patents
Top patents by PatentIndex Score
US6492399B1Dec 10, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC120 citations98
US6166048ADec 26, 2000
Pharmaceutical compositions for inhibition of cytokine production and secretion
TARGACEPT INC105 citations98
US6953855B2Oct 11, 2005
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
TARGACEPT INC71 citations97
US6274606B1Aug 14, 2001
Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds
TARGACEPT INC46 citations96
US6232316B1May 15, 2001
Methods for treatment of CNS disorders
TARGACEPT INC48 citations96
US7425561B2Sep 16, 2008
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
TARGACEPT INC22 citations95
US6455554B1Sep 24, 2002
Oxopyridinyl pharmaceutical compositions and methods for use
TARGACEPT INC77 citations94
US6743812B1Jun 1, 2004
Pharmaceutical compositions and methods for use
TARGACEPT INC22 citations93
US7767193B2Aug 3, 2010
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
TARGACEPT INC15 citations92
US7714001B2May 11, 2010
Arylvinylazacycloalkane compounds and methods of preparation and use thereof
TARGACEPT INC13 citations92
US7098331B2Aug 29, 2006
Arylvinylazacycloalkane compounds and methods of preparation and use thereof
TARGACEPT INC15 citations92
US6958399B2Oct 25, 2005
Compounds capable of activating cholinergic receptors
TARGACEPT INC28 citations92
US6956042B2Oct 18, 2005
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
TARGACEPT INC19 citations92
US6624173B1Sep 23, 2003
Pharmaceutical compositions for treating and/or preventing CNS disorders
TARGACEPT INC39 citations92
US6603011B1Aug 5, 2003
3-pyridinyl compounds
TARGACEPT INC38 citations92
US6555684B2Apr 29, 2003
Pyrimidinyl compounds for treatment of central nervous system disorders
TARGACEPT INC25 citations92
US6531606B1Mar 11, 2003
Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
TARGACEPT INC22 citations92
US6525065B1Feb 25, 2003
Pharmaceutical compositions and methods for effecting dopamine release
TARGACEPT INC24 citations92
US6489349B1Dec 3, 2002
Pharmaceutical compositions for inhibition of cytokine production and secretion
TARGACEPT INC31 citations92
US6417359B1Jul 9, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC33 citations92
US6337351B1Jan 8, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC32 citations92
US6310102B1Oct 30, 2001
Pharmaceutical compositions and methods for use
TARGACEPT INC27 citations92
US6218383B1Apr 17, 2001
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
TARGACEPT INC37 citations92
US7981906B2Jul 19, 2011
(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
TARGACEPT INC29 citations91
US7459469B2Dec 2, 2008
Hydroxybenzoate salts of metanicotine compounds
TARGACEPT INC20 citations91
US7214686B2May 8, 2007
Pharmaceutical compositions and methods for effecting dopamine release
TARGACEPT INC28 citations91
US6432954B1Aug 13, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC24 citations91
US9145396B2Sep 29, 2015
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
TARGACEPT INC16 citations90
US6432975B1Aug 13, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC19 citations84
US7897611B2Mar 1, 2011
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
TARGACEPT INC10 citations82
US6979695B2Dec 27, 2005
Compounds capable of activating cholinergic receptors
TARGACEPT INC13 citations82
US7307092B2Dec 11, 2007
Compounds Capable of Activating Cholinergic Receptors
TARGACEPT INC9 citations73
US7060826B2Jun 13, 2006
Compounds capable of activating cholinergic receptors
TARGACEPT INC10 citations73
US7754189B2Jul 13, 2010
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
TARGACEPT INC3 citations72
US7045538B2May 16, 2006
Compounds capable of activating cholinergic receptors
TARGACEPT INC8 citations72
US6440970B1Aug 27, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC7 citations72
US9532974B2Jan 3, 2017
Nicotinic receptor non-competitive antagonists
TARGACEPT INC2 citations71
US7402592B2Jul 22, 2008
Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
TARGACEPT INC7 citations71
US6624167B1Sep 23, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC11 citations71
US6627648B1Sep 30, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC9 citations68
US6890935B2May 10, 2005
Pharmaceutical compositions and methods for use
TARGACEPT INC2 citations63
US7923559B2Apr 12, 2011
N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
TARGACEPT INC1 citations62
US7375110B2May 20, 2008
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
TARGACEPT INC1 citations62
US7291731B2Nov 6, 2007
N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
TARGACEPT INC3 citations62
US8778978B2Jul 15, 2014
Hydroxybenzoate salts of metanicotine compounds
TARGACEPT INC2 citations61
US6852721B2Feb 8, 2005
Pharmaceutical compositions and methods for use
TARGACEPT INC5 citations61
US6579878B1Jun 17, 2003
Pharmaceutical compositions and methods for use
TARGACEPT INC5 citations61
US6441007B1Aug 27, 2002
Pharmaceutical compositions and methods for use
TARGACEPT INC4 citations61
US8901151B2Dec 2, 2014
Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
TARGACEPT INC3 citations59
US9173876B2Nov 3, 2015
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
TARGACEPT INC1 citations58
Showing the top 50 of 62 patents by PatentIndex Score.